Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,641 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07162168Recruiting
Using AI to measure bone age from abdominal CT scans
This study uses artificial intelligence to estimate bone age from standard abdominal CT scans. It may help researchers understand how bone age relates to health conditions without extra X-rays.
BeijingAges 18 years+ - NCT07162779Enrolling by invitation
New PET scan for advanced prostate cancer patients
This trial tests a new type of PET scan using a radioactive tracer called [68Ga]DOTA-IR-780-C-4 to see if it can find prostate cancer cells that express a protein called PSMA. If you have advanced prostate cancer that has stopped responding to standard treatments, this scan may help your doctor better understand your cancer and possibly guide future care.
Wuxi, JiangsuAges 18–80 - NCT07163013Recruiting
Digital therapy for teens with depression
This trial tests a digital therapy (a phone- or computer-based program) that teaches you skills to manage depression. It is designed for Chinese-speaking teens who have moderate to severe depression and are not currently receiving other treatment.
ChongqingAges 12–18 - NCT04707443Recruiting
Feeding support for newborns with a small-bowel stoma
This trial looks at how to provide nutrition by mouth or through a feeding tube (enteral feeding) for babies who have a small-bowel stoma (an opening made for stool to leave the body). It may help babies grow and get adequate nutrition while they recover.
Shanghai, Shanghai MunicipalityAges Up to 6 months - NCT06555900Recruiting
Predicting brain pressure spikes in injured patients using AI
This study is testing if an artificial intelligence program can predict dangerous increases in pressure inside the skull of people with brain injuries. If successful, it could help doctors treat these episodes sooner.
BrestAges 18–99 - NCT06551831Recruiting
Understanding end-of-life decisions in young adults with advanced cancer
This study talks with young adults aged 15-39 with advanced, spreading cancer to understand how they and their doctors make decisions about end-of-life care. The goal is to improve support for patients facing these tough choices.
TaipeiAges 18–39 - NCT07157618Recruiting
Pathology study for patients with slides and records
This trial uses your stored tissue slides and medical history to build a better pathology research tool. It may help future patients get more accurate diagnoses.
Guangzhou, GuangdongAges 18–75 - NCT06852755Recruiting
Finding markers to track menopause in women
This study looks for biological signs that can help monitor menopause. It may help women understand their menopause transition better.
New Taipei CityAges 20 years+ - NCT07150559Recruiting
Arch-clamping under mild cooling for acute aortic dissection
This trial tests a surgical technique called arch-clamping under mild hypothermia (cooling the body slightly during surgery) to treat acute type A aortic dissection. It may help patients who need immediate total aortic arch replacement.
Beijing, Beijing MunicipalityAges 18–70 - NCT06817616Recruiting
Rotator cuff repair with stem cells for large shoulder tears
This trial tests whether adding umbilical cord stem cells to standard arthroscopic rotator cuff repair helps heal large or massive tears better. It may be an option if you have had shoulder pain for at least three months and other treatments haven't worked.
Seoul, KoreaAges 19 years+ - NCT05642013Recruiting
Short interval exchange surgery for infected hip or knee implants
This study compares how to replace an infected hip or knee implant using a two-step surgery with a shorter waiting time. It aims to reduce the time between surgeries while still safely treating the infection.
MontpellierAges 18 years+ - NCT06974123Enrolling by invitationPhase 1/Phase 2
Testing a new oral drug for radiation proctitis
This trial tests an oral drug called Teslanbaicin for people who have pelvic cancer and developed radiation proctitis (inflammation of the rectum from radiation therapy). The goal is to see if it is safe and helps heal the inflammation.
Xinxiang, HenanAges 18 years+ - NCT07147426RecruitingPhase 2
Tislelizumab plus chemo before surgery for head and neck cancer
This trial tests whether giving the immunotherapy drug tislelizumab with chemotherapy before surgery can help people with advanced head and neck cancer. The goal is to shrink the tumor enough to remove it completely during surgery.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT06553612Recruiting
Supportive care planning after gynecological cancer treatment
This study compares a special day-hospital visit focused on supportive care needs to standard follow-up for people who have finished initial treatment for ovarian or endometrial cancer. The goal is to see if the special visit helps more people get the supportive care they need.
BesançonAges 18 years+ - NCT07146828Recruiting
High-precision vision test for laser eye surgery
This trial tests a very precise way to measure vision (0.05 diopter steps) for people getting SMILE laser eye surgery. The goal is to see if this fine-tuning leads to better results.
Nantong, JiangsuAges 18–40 - NCT04707001Recruiting
Tests urine problems after knee replacement surgery
This study looks at urinary retention (when you can’t pee normally) after elective total knee replacement. It may help doctors understand who is at risk and how to reduce this problem after surgery.
JyväskyläAges 18 years+ - NCT07136792Recruiting
New injection for anemia in dialysis patients taking roxadustat
This study tests a new once-monthly injection called pegmolesatide for anemia in people with kidney disease on dialysis who are already taking roxadustat. It aims to see if switching to this injection can keep hemoglobin levels stable and reduce the need for transfusions.
Beijing, Beijing MunicipalityAges 18–75 - NCT06553911Recruiting
AI tools for diagnosing respiratory infections
This trial uses artificial intelligence (AI) to help doctors read X-rays or CT scans of people with respiratory infections. The goal is to see if AI can make diagnosis faster and more accurate.
ShanghaiAges 1–90 - NCT07270887Recruiting
Can gentle arm cuffs protect your heart and brain over time?
This trial tests if using a blood pressure cuff on your arm in short cycles can help prevent future heart attacks, strokes, and other problems in people at very high risk. You may qualify if you've already had a major heart or blood vessel event.
ShenyangAges 40 years+ - NCT07143929RecruitingPhase 1
CD7-targeted CAR-T therapy for relapsed or refractory peripheral T-cell lymphoma
This trial tests a new type of immunotherapy called CAR-T that targets a protein called CD7 on cancer cells. It is for people with peripheral T-cell lymphoma that has come back or not responded to at least one prior treatment.
BeijingAges 18–80 - NCT07142785Recruiting
Peeling or Not Peeling for Idiopathic Epiretinal Membrane Surgery
This study compares two surgical approaches for treating an idiopathic epiretinal membrane (a thin layer of scar tissue on the retina). It aims to see whether peeling the inner layer of the retina during surgery leads to better vision and fewer visual distortions.
Hangzhou, ZhejiangAges 18 years+ - NCT07382700Enrolling by invitation
Blood markers in heart attack patients treated with stents
This study looks at certain fats in the blood of people having a severe heart attack called STEMI. Researchers want to see if these fats can help understand what happens in the body during a heart attack.
Ningbo, ZhejiangAges 50–70 - NCT07138027Recruiting
Asthma control study for kids at CHOP clinics
This study looks at ways to improve asthma care for children who have uncontrolled asthma. It tests how well different approaches work at CHOP pediatric clinics to help kids breathe better.
Philadelphia, PennsylvaniaAges 5–18 - NCT05699811RecruitingPhase 1/Phase 2
Test of special immune-support cells for solid tumors
This study tests lab-made mesenchymal stromal cells that release interferon alpha (IFNα) for people with locally advanced or metastatic solid cancers. It’s designed to see if this treatment can help when standard treatments have failed or don’t have guideline options.
BeijingAges 18–75
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,641 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.